Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « proposed »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
propose < proposed < proposes  Facettes :

List of bibliographic references indexed by proposed

Number of relevant bibliographic references: 77.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000037 (2021) Isabel Fambuena-Muedra [Espagne] ; Marta Jiménez-García [Belgique] ; Sarah Hershko [Belgique] ; Irene Altemir-G Mez [Espagne] ; Ana Tobarra-L Pez [Espagne]What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects.
000062 (2021) Mohamed A. Taha [États-Unis, Égypte] ; Christian A. Hall [États-Unis] ; Colin J. Shortess [États-Unis] ; Richard F. Rathbone [États-Unis] ; Henry P. Barham [États-Unis]Treatment Protocol for COVID-19 Based on T2R Phenotype.
000146 (2021) Rahul Sharma [Inde] ; Dharmendra Khokhar [Inde] ; Bhanushree Gupta [Inde] ; Purnendu Saxena [Inde] ; Kallol Kumar Ghosh [Inde] ; Arvind Kumar Geda [Inde] ; Kamil KucaSevere Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics.
000264 (2021) Yanqiang Han ; Zhilong Wang ; Jiahao Ren ; Zhiyun Wei ; Jinjin Li [République populaire de Chine]Potential inhibitors for the novel coronavirus (SARS-CoV-2).
000291 (2021) Eleni Karatza [Grèce] ; George Ismailos [Grèce] ; Markos Marangos [Grèce] ; Vangelis Karalis [Grèce]Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients' characteristics: a review of the literature and simulations.
000311 (2021) Aitebiremen Gift Omokhua-Uyi [Afrique du Sud] ; Johannes Van Staden [Afrique du Sud]Natural product remedies for COVID-19: A focus on safety.
000332 (2021) R K Hussein [Arabie saoudite] ; H M Elkhair [Arabie saoudite, Soudan]Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19.
000347 (2021) Benjamin Coiffard [France] ; Philipp M. Lepper [Allemagne] ; Eloi Prud'Homme [France] ; Florence Daviet [France] ; Nadim Cassir [France] ; Heinrike Wilkens [Allemagne] ; Sami Hraiech [France] ; Frank Langer [Allemagne] ; Pascal A. Thomas [France] ; Martine Reynaud-Gaubert [France] ; Robert Bals [Allemagne] ; Hans-Joachim Sch Fers [Allemagne] ; Laurent Papazian [France] ; Frederik Seiler [Allemagne]Management of lung transplantation in the COVID-19 era-An international survey.
000370 (2021) Ágnes Telbisz [Hongrie] ; Csilla Ambrus [Hongrie] ; Orsolya M Zner [Hongrie] ; Edit Szab [Hongrie] ; György Várady [Hongrie] ; Éva Bakos [Hongrie] ; Balázs Sarkadi [Hongrie] ; Csilla Özvegy-Laczka [Hongrie]Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters.
000407 (2021) Anca Pantea Stoian [Roumanie] ; Doina Catrinoiu [Roumanie] ; Manfredi Rizzo [États-Unis, Italie] ; Antonio Ceriello [Italie]Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story.
000454 (2021) Hang Xu [République populaire de Chine] ; Xiang Yang Zhang [République populaire de Chine] ; Wei Wen Wang [République populaire de Chine] ; Jiesi Wang [République populaire de Chine]Hydroxychloroquine Increased Anxiety-Like Behaviors and Disrupted the Expression of Some Related Genes in the Mouse Brain.
000521 (2021) Daniela R. Junqueira [Canada] ; Brian H. Rowe [Canada]Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID-19 pandemic.
000639 (2021) Amin Gasmi [France] ; Massimiliano Peana [Italie] ; Sadaf Noor [Pakistan] ; Roman Lysiuk [Ukraine] ; Alain Menzel [Luxembourg (pays)] ; Asma Gasmi Benahmed [France] ; Geir Bj Rklund [Norvège]Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
000662 (2021) Christian A. Devaux [France] ; Laurence Camoin-Jau [France] ; Jean-Louis Mege [France] ; Didier Raoult [France]Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
000681 (2021) Noha Mousaad Elemam ; Azzam A. Maghazachi ; Suad HannawiCOVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remedies.
000718 (2021) Moamen S. Refat [Arabie saoudite] ; Anas A. Sedayo [Arabie saoudite] ; Ali Sayqal [Arabie saoudite] ; Arwa Alharbi [Arabie saoudite] ; Hanadi A. Katouah [Arabie saoudite] ; Hana M. Abumelha [Arabie saoudite] ; Seraj Alzahrani [Arabie saoudite] ; Fatmah Alkhatib [Arabie saoudite] ; Ismail Althagafi [Arabie saoudite] ; Nashwa El-Metwaly [Arabie saoudite, Égypte]Aurintricarboxylic acid and its metal ion complexes in comparative virtual screening versus Lopinavir and Hydroxychloroquine in fighting COVID-19 pandemic: Synthesis and characterization.
000756 (2021) Süleyman Bodur [Turquie] ; Sezin Erarpat [Turquie] ; Ömer Tahir Günkara [Turquie] ; Sezgin Bak Rdere [Turquie]Accurate and sensitive determination of hydroxychloroquine sulfate used on COVID-19 patients in human urine, serum and saliva samples by GC-MS.
000761 (2021) S Udhaya Kumar [Inde] ; N Madhana Priya [Inde] ; S R Nithya [Inde] ; Priyanka Kannan [Inde] ; Nikita Jain [Inde] ; D Thirumal Kumar [Inde] ; R. Magesh [Inde] ; Salma Younes [Qatar] ; Hatem Zayed [Qatar] ; C George Priya Doss [Inde]A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing.
000765 (2021) Eric Duverger [France] ; Guillaume Herlem [France] ; Fabien Picaud [France]A potential solution to avoid overdose of mixed drugs in the event of Covid-19: Nanomedicine at the heart of the Covid-19 pandemic.
000780 (2021) Tien-Tzu Tai [Taïwan] ; Tzung-Ju Wu [Taïwan] ; Huey-Dong Wu [Taïwan] ; Yi-Chen Tsai [Taïwan] ; Hui-Ting Wang [Taïwan] ; An-Min Wang [Taïwan] ; Sheue-Fang Shih [Taïwan] ; Yee-Chun Chen [Taïwan]A Strategy to Treat COVID-19 Disease With Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Preclinical Pharmacokinetic Study.
000848 (2020) Anuj Sharma [États-Unis]Chloroquine paradox may cause more damage than help fight COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "proposed" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "proposed" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    proposed
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021